[go: up one dir, main page]

BR0312640A - Formulação contra mycoplasma gallisepticum - Google Patents

Formulação contra mycoplasma gallisepticum

Info

Publication number
BR0312640A
BR0312640A BR0312640-4A BR0312640A BR0312640A BR 0312640 A BR0312640 A BR 0312640A BR 0312640 A BR0312640 A BR 0312640A BR 0312640 A BR0312640 A BR 0312640A
Authority
BR
Brazil
Prior art keywords
mycoplasma gallisepticum
formulation
formulation against
against mycoplasma
birds
Prior art date
Application number
BR0312640-4A
Other languages
English (en)
Inventor
Stanley H Kleven
Naola Ferguson
Original Assignee
Univ Georgia Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Found filed Critical Univ Georgia Res Found
Publication of BR0312640A publication Critical patent/BR0312640A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"FORMULAçãO CONTRA MYCOPLASMA GALLISEPTICUM". A presente invenção refere-se a uma formulação protetora que previne infecção virulenta por Mycoplasma gallisepticum em aves da ordem Galliformes. A formulação compreende uma quantidade protetora da cepa K5054 viva de MG ou derivados dela, em um veículo farmaceuticamente aceitável. Apresenta-se também uma vacina que previne infecção virulenta por Mycoplasma gallisepticum em aves da ordem Galliformes. Métodos para administrar a formulação e a vacina também são apresentados.
BR0312640-4A 2002-07-13 2003-07-10 Formulação contra mycoplasma gallisepticum BR0312640A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/194,180 US7217420B2 (en) 2002-07-13 2002-07-13 Mycoplasma gallisepticum formulation
PCT/US2003/022011 WO2004006851A2 (en) 2002-07-13 2003-07-10 Mycoplasma gallisepticum formulation

Publications (1)

Publication Number Publication Date
BR0312640A true BR0312640A (pt) 2005-06-28

Family

ID=30114683

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312640-4A BR0312640A (pt) 2002-07-13 2003-07-10 Formulação contra mycoplasma gallisepticum

Country Status (11)

Country Link
US (2) US7217420B2 (pt)
EP (1) EP1531861A4 (pt)
JP (1) JP2005533116A (pt)
KR (1) KR20050074428A (pt)
CN (1) CN1688336A (pt)
AU (1) AU2003267992A1 (pt)
BR (1) BR0312640A (pt)
MX (1) MXPA05000467A (pt)
RU (1) RU2005104100A (pt)
WO (1) WO2004006851A2 (pt)
ZA (1) ZA200500169B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007115207A2 (en) * 2006-03-31 2007-10-11 Regents Of The University Of Minnesota Irf-5 haplotypes in systemic lupus erythematosus
TWI422594B (zh) * 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
CL2008002675A1 (es) * 2007-09-11 2008-11-07 Wyeth Corp Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados.
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
CN102292432B (zh) * 2009-01-22 2013-05-22 乔治亚大学研究基金公司 鸡败血支原体制剂
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
MX357432B (es) * 2013-03-18 2018-07-09 Intervet Int Bv Vacuna para proteger a un rumiante contra la neumonia causada por mannheimia haemolytica.
MX2024011270A (es) * 2022-04-06 2024-09-25 Univ Georgia Vacunas vivas contra mycoplasma gallisepticum.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137306A (en) 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS52134019A (en) 1976-04-28 1977-11-09 Biseibutsu Kagaku Kenkiyuushiy Micoplasma galicepticum infection vaccine
US5004607A (en) 1987-08-25 1991-04-02 University Of Georgia Research Foundation, Inc. Method of immunizing poultry
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
EP0345021B1 (en) 1988-06-02 1994-04-27 Nippon Zeon Co., Ltd. Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
KR100262208B1 (ko) 1992-05-29 2000-07-15 나카노 카쯔히코 가금 마이코플라스마 항원, 그의 유전자, 그 유전자를 함유한 재조합 벡터, 및 이를 이용한 백신
DE69435209D1 (de) 1993-03-31 2009-06-10 Zeon Corp Polypeptid, dafür kodierende DNA, diese DNA beinhaltender, rekombinanter Vektor, Herstellung eines rekombinanten Virus unter Verwendung dieses Vektors und dessen Anwendung
PT639640E (pt) 1993-07-30 2001-03-30 Akzo Nobel Nv Vacina para aves domesticas com infeccoes provocadas pela estirpe 4/91 do virus da bronquite
JPH07133295A (ja) 1993-08-27 1995-05-23 Nippon Zeon Co Ltd 新規な抗原タンパク質、その遺伝子、及び組み換えバキュロウイルスとその利用
JPH07228542A (ja) 1994-02-18 1995-08-29 Nippon Seibutsu Kagaku Kenkyusho 不活化病原体の鶏用気管内投与ワクチン
AU4486096A (en) 1995-01-06 1996-07-24 Akzo Nobel N.V. Chicken anaemia agent broiler vaccine
ZA978434B (en) 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Also Published As

Publication number Publication date
ZA200500169B (en) 2006-06-28
WO2004006851A3 (en) 2004-03-18
JP2005533116A (ja) 2005-11-04
MXPA05000467A (es) 2005-09-30
US20040009179A1 (en) 2004-01-15
AU2003267992A8 (en) 2004-02-02
EP1531861A2 (en) 2005-05-25
US20060257414A1 (en) 2006-11-16
CN1688336A (zh) 2005-10-26
RU2005104100A (ru) 2005-08-27
US7217420B2 (en) 2007-05-15
WO2004006851A2 (en) 2004-01-22
AU2003267992A1 (en) 2004-02-02
KR20050074428A (ko) 2005-07-18
EP1531861A4 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
BRPI0408999A (pt) comprimidos prensados de multiparticulados de liberação oral prolongada
MX2020005779A (es) Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y metodos de uso de estos.
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
BRPI0415953A (pt) formulação de dosagem de liberação controlada oral, método de tratamento de um distúrbio, conjunto de formas de dosagem de liberação controlada e método para administração da formulação
WO2003003941A3 (en) One dose vaccination with mycoplasma hyopneumoniae
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
BR9815255A (pt) Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal
CY1111446T1 (el) Συνθεσεις περιλαμβανουσες κρυσταλλικη trans- (+/-)-δελτα-9-τετραϋδροκανναβινολη
BRPI0510430A (pt) composições e métodos para vacinação mucosal
BR112013006396A2 (pt) composições imunogênicas
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BR0211492A (pt) Vacina para west nile
BR9807199A (pt) Composição oral e processo para o tratamento e a prevenção de acúmulo de placa bacteriana sobre dentes.
BR0212556A (pt) interleucina-12 como um adjuvante de vacina veterinária
BR0309837A (pt) Forma de administração trans-epicutânea para tratamento da sìndrome das pernas inquietas
BR0014902A (pt) Formulações orais para compostos antitumorais
BR112021024491A8 (pt) Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição
BR0312640A (pt) Formulação contra mycoplasma gallisepticum
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
BR0015149A (pt) Método e composições para administração de taxanos oralmente a pacientes humanos
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
CO2022016537A2 (es) Vacuna inactivada para sars-cov-2 y preparación de la misma
PE20011113A1 (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010.